RMAT designation enables intensified FDA engagement and potential accelerated pathways, implying preliminary clinical evidence for RTx-015 despite absent peer-reviewed efficacy details, endpoints, and ...
Scientists have developed new tools to improve gene therapy in advanced stages of inherited retinal diseases (IRDs) such as retinitis pigmentosa and Leber congenital amaurosis. Inherited retinal ...
Inherited retinal degenerations (IRDs) are a group of genetic disorders that lead to progressive vision loss as the light-sensing cells of the eye—the photoreceptors—die due to mutations in genes ...
Buck Institute professor Pankaj Kapahi thinks the eye is a window to aging. His lab, in collaboration with Google Health and Zuckerberg San Francisco General Hospital, has shown how imaging of the ...
Many retinal diseases begin long before patients experience noticeable vision loss.Clinicians frequently manage patients with ...
Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. Sign up (BPT) – Healthy sight allows you to see all of the world’s ...
Nanoscope Therapeutics, Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor loss and vision impairment due to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results